Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-31

FDA Approved: CLINDAMYCIN PHOSPHATE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a new original application for clindamycin phosphate, a generic formulation manufactured by Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDAMYCIN PHOSPHATE (Clindamycin phosphate)

Snippet

ORIG AP for CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)